Dewpoint Therapeutics

About:

Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates.

Website: https://dewpointx.com

Twitter/X: dewpointtx

Top Investors: Alexandria Venture Investments, General Catalyst, ARCH Venture Partners, SoftBank Vision Fund, Polaris Partners

Description:

Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates. Its technology uses machine-learning-based image analysis tools for visualizing condensates and offers an engine for genetically linked condensatopathy which is a collection of engineered cell lines with trackable condensates to prevent harmful protein sequestration, helping healthcare providers to have access to new therapies to address unmet needs. The company was founded in 2018 and is headquartered in Boston, Massachusetts.